Mr. Gil Bianco

• 
  www.biospace.com/news_story.aspx?NewsEntityId=65745 - [Cached Version]
  Published on: 8/7/2007    Last Visited: 8/8/2007  

  JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, announced today that Tamar Howson, Gil Bianco and Ilan Leviteh have been appointed to the Company's board of directors.

• 
  www.ntt-inc.com/AboutUs/ManagementAdvisors/tabid/61/Def - [Cached Version]
  Published on: 9/27/2009    Last Visited: 9/27/2009  

  Gil Bianco, CPA
  
  Mr Bianco has over 20 years of executive management experience. Before joining NTT, Mr. Bianco served as the CEO for Agis Industries from 2001 to 2003. Throughout his employment with Agis (in various decision making positions), Mr. Bianco actively participated in transforming Agis Industries Ltd. from a local import enterprise with $15 million turnover to an internationally known pharmaceutical company with a turnover of about $290 million, owning six factories. In 1992, Mr. Bianco helped lead the IPO of the company on the Tel-Aviv Stock Exchange. In 1994 he played an active part in the acquisition by Agis of Clay-Park Labs Inc. in the U.S.A., and was appointed to Clay-Park's Board of Directors.

• 
  www.sec.gov/Archives/edgar/data/1211805/0001362310-08-0 - [Cached Version]
  Published on: 3/4/2008    Last Visited: 3/7/2008  

  Gil Bianco(2)(3)
  ...
  Mr. Bianco resigned from our Board of Directors and from our Audit Committee on February 10, 2008.
  ...
  Gil Bianco Mr. Bianco resigned from our Board of Directors and from our Audit Committee on February 10, 2008.
  ...
  Our Board of Directors determined that as of December 31, 2007, the Company had at least one audit committee financial expert serving on the Company's Audit Committee, Zvi Schechter and Gil Bianco.
  ...
  Under the independence standards required by a national securities exchange, the Nasdaq Stock Market, Inc., for audit committee members, as of December 31, 2007, Gil Bianco was independent and Zvi Schechter was not independent.
  ...
  Gil Bianco resigned from our Board of Directors and from our Audit Committee on February 10, 2008.

• 
  www.knowledgeexpress.com/local/detail.asp?id=9611299&so - [Cached Version]
  Published on: 8/7/2007    Last Visited: 8/15/2007  

  Jerusalem, Israel, August 7, 2007 , BioLineRx Ltd. (TASE: BLRX), Israel,s leading drug development company announced today that Tamar Howson, Gil Bianco and Ilan Leviteh have been appointed to the Company's board of directors.
  ...
  Mr. Bianco served as the CEO of Agis Industries Ltd. from 2001 to 2003.Throughout his employment with Agis, Mr. Bianco actively participated in transforming Agis into an internationally known pharmaceutical company with revenues of more than $350 million.In 1992, as Agis, CFO, Mr. Bianco helped lead the IPO of the company on the Tel Aviv Stock Exchange.Mr. Bianco also serves as a director of five additional life science companies, and of the Tel Aviv stock exchange since 2003.

• 
  About us - Board of Directors - [Cached Version]
  Published on: 10/26/2009    Last Visited: 10/26/2009  

  GIL BIANCO Mr. Bianco served as the CEO of Agis Industries Ltd. from 2001 to 2003. Throughout his employment with Agis, Mr. Bianco actively participated in transforming Agis into an internationally known pharmaceutical company with revenues of more than $350 million. In 1992, as Agis' CFO, Mr. Bianco helped lead the IPO of the company on the Tel Aviv Stock Exchange. He currently serves as a Director at BioCancell Therapeutics Inc., Topspin Medical Inc., Fischer Pharmaceutical-Labs, Novel Therapeutic Technologies Ltd., HealOr Ltd., Sol-Gel Technologies Ltd. and the Tel Aviv Stock Exchange since 2003. Mr. Bianco received his B.A. in Economics and Accounting from Tel-Aviv University.

• 
  Agis - [Cached Version]
  Published on: 6/19/2003    Last Visited: 11/8/2005  

  In connection with reports published today in the media regarding departure of Gil Bianco from the position of the CEO of the Company, the Company wishes to clarify the following:
  ...
  Following the enactment of the New Companies Law and the separation required between the functions of the CEO and the functions of the Chairman of the Board of Directors, Mr. Moshe Arkin resigned two and one half years ago from his position as CEO of the Company and was appointed as President and active Chairman of the Board of Directors of the Company, and Gil Bianco was appointed as CEO.
  ...
  In the context of Mr Moshe Arkin's desire to increase his involvement in the executive aspects of the Company, and in order to avoid a state of affairs that is not in line with the provisions of the Companies Law concerning the separation of the authority of the Chairman of the Board of Directors from that of the CEO of the Company, the Board of Directors of the Company has decided on organizational changes that shall be implemented in the coming months, pursuant to which Mr. Moshe Arkin will be appointed as the CEO of the Company, Mr. Rafael Lebel will be appointed as Deputy CEO of the Company, and Mr. Gil Bianco will be appointed as special consultant to the Company and its subsidiaries.
  ...
  The date that has been set for the conclusion of Gil Bianco's appointment as CEO of the Company and for the appointment of Mr. Moshe Arkin is September 30, 2003.

• 
  BioCancell - [Cached Version]
  Published on: 4/8/2008    Last Visited: 4/8/2008  

  Gil Bianco, CPAAs CEO of Agis Industries, the company's annual turnover rose to $290 million, with around 2000 employees, making it the second-largest pharmaceuticals company in Israel.Previously, as CFO, he was a full partner in the transformation of Agis from a local import company, while leading the company's IPO on the Tel Aviv Stock Exchange.
  
  Mr Bianco currently runs a consulting firm specializing in business management and initiation in the fields of pharmaceuticals and real estate.He serves on the Board of Directors of the Tel Aviv Stock Exchange and in several medical and pharmaceutical companies, including Colbar Lifescience, Novel Therapeutic Technologies and Fischer Pharmaceutical Labs.He is a CPA and holds a B.A. in Economics and Accounting from the Tel-Aviv University.

• 
  HealOr - Board of Directors - [Cached Version]
  Published on: 9/27/2009    Last Visited: 9/27/2009  

  Mr. Gil Bianco, CPA(Isr.)
  
  Mr. Bianco has over 20 years of executive management experience. Before joining HealOr, Mr. Bianco served as CEO of Agis Industries where he has transformed Agis Ltd. from a local enterprise with a turnover of $15 million into a multimillion dollar internationally known pharmaceutical company. In 1992, Mr. Bianco lead the IPO of Agis on the Tel-Aviv Stock Exchange and in 1994 he played an active part in the acquisition of Clay-Park Labs Inc. by Agis and was appointed to Clay-Park's Board of Directors. He is currently director at the Tel-Aviv Stock Exchange, Topspin Medical, Biocancell and is involved in several other biotech companies.

• 
  NTT NOVEL THERAPEUTIC TECHNOLOGIES - [Cached Version]
  Published on: 6/9/2009    Last Visited: 6/9/2009  

  Gil Bianco, CPA Mr Bianco has over 20 years of executive management experience. Before joining NTT, Mr. Bianco served as the CEO for Agis Industries from 2001 to 2003. Throughout his employment with Agis (in various decision making positions), Mr. Bianco actively participated in transforming Agis Industries Ltd. from a local import enterprise with $15 million turnover to an internationally known pharmaceutical company with a turnover of about $290 million, owning six factories. In 1992, Mr. Bianco helped lead the IPO of the company on the Tel-Aviv Stock Exchange. In 1994 he played an active part in the acquisition by Agis of Clay-Park Labs Inc. in the U.S.A., and was appointed to Clay-Park's Board of Directors.

• 
  News and Events - News Archive - [Cached Version]
  Published on: 7/6/2009    Last Visited: 10/26/2009  

  BioLineRx Ltd. (TASE: BLRX), Israel's leading drug development company announced today that Tamar Howson, Gil Bianco and Ilan Leviteh have been appointed to the Company's board of directors.

Page:  1 2